Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Sinusoidal communication in chronic liver disease

Albert Gibert-Ramos, María Andrés-Rozas, Raül Pastó, Pablo Alfaro-Retamero, Sergi Guixé-Muntet, Jordi Gracia-Sancho

Clin Mol Hepatol. 2025;31(1):32-55. Published online October 2, 2024

DOI: https://doi.org/10.3350/cmh.2024.0734

View: 1842 Download: 222 Web of Science: 2 Crossref: 1

Special Issue

KASL clinical practice guidelines for noninvasive tests to assess liver fibrosis in chronic liver disease

Mi Na Kim, Ji Won Han, Jihyun An, Beom Kyung Kim, Young-Joo Jin, Seung-seob Kim, Minjong Lee, Han Ah Lee, Yuri Cho, Hee Yeon Kim, Yu Rim Shin, Jung Hwan Yu, Moon Young Kim, YoungRok Choi, Young Eun Chon, Eun Ju Cho, Eun Joo Lee, Sang Gyune Kim, Won Kim, Dae Won Jun, Seung Up Kim, on behalf of The Korean Association for the Study of the Liver (KASL)

Clin Mol Hepatol. 2024;30(Suppl):S5-S105. Published online August 19, 2024

DOI: https://doi.org/10.3350/cmh.2024.0506

View: 2927 Download: 221 Web of Science: 6 Crossref: 10

Review

Clinical applications of transient elastography

Kyu Sik Jung, Seung Up Kim

Clin Mol Hepatol. 2012;18(2):163-173. Published online June 26, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.2.163

View: 13251 Download: 130 Crossref: 84

Original Article

A study of the awareness of chronic liver diseases among Korean adults

Dae Won Jun, Yong Kyun Cho, Joo Hyun Sohn, Chang Hyeong Lee, Seok Hyun Kim, Jong Ryul Eun

Clin Mol Hepatol. 2011;17(2):99-105. Published online June 23, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.2.99

View: 8597 Download: 55 Crossref: 13

3

Clinical factors influencing Liver stiffness as measured by transient elastography (FibroscanⓇ) in patients with chronic Liver disease

Rack Cheon Bae, M.D., Han Jin Cho, M.D., Jong Taek Oh, M.D., Eung Kap Lee, M.D., Jun Heo, M.D., Keun Young Shin, M.D., Soo Young Park, M.D., Min Kyu Jeong, M.D., Seong Woo Jeon, M.D., Chang Min Cho, M.D., Won Young Tak, M.D., Young Oh Kweon, M.D.

Clin Mol Hepatol. 2010;16(2):123-130. Published online June 25, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.2.123

View: 5802 Download: 62 Crossref: 8

Clinical Significance of Autonomic Neuropathy in Liver Cirrhosis

Jae Hong Park, M.D., Sung Woo Jeon, M.D., Min Kyu Jung, M.D., Jong Hyub Lee, M.D., Chang Min Cho, M.D., Won Young Tak, M.D., Young Oh Kweon, M.D., Sung Kook Kim, M.D., Yong Hwan Choi, M.D., Joon Mo Chung, M.D., Ki Soo Park, M.D.*

Clin Mol Hepatol. 2001;7(2):153-161. Published online January 1, 2000

View: 3000 Download: 15

Implications of Serum Levels of Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor in Chronic Liver Diseases and Hepatocellular Carcinoma

Sung Jae Yoo, M.D, Sung Moon Jung, M.D, Jong Gwang Kim, M.D, Jin Ok Lee, M.D, Yong Whan Song, M.D, Chul Ju Han, M.D, Sook-Hyang Jung, M.D, You Cheoul Kim, M.D, Chang-Min Kim, M.D, Jhin Oh Lee, M.D, Young Joon Hong, M.D* and Seok Il Hong, M.D*

Clin Mol Hepatol. 2001;7(1):47-54. Published online January 1, 2000

View: 2564 Download: 20

Efficacy of Lamivudine in Patients with HBeAg-Negative and HBV DNA-Positive Chronic Liver Disease

Hye Seung Yoo,Han Joo Lee,Young Hwa Jung,Young Sang Lee,Dong Jin Seo

Clin Mol Hepatol. 2000;6(4):488-494. Published online January 1, 2000

View: 2449 Download: 13

A Prospective Study of Therapeutic Effect of 6 Months Trial with Lamivudine in Patients with Chronic Viral Hepatitis B

Chang Woo Gham,Soong Hwan Lee,Seung Woo Nam,Seung Woo Nam,Byung Joo Roh,Dong Hoo Lee

Clin Mol Hepatol. 1999;5(4):282-290. Published online January 1, 2000

View: 2463 Download: 11

Distinct Expressions of TGF - α among Chronic Hepatitis , Liver Cirrhosis , and Hepatocellular Carcinoma

Byeong Moo Yoo , Sung Soo Park , Dong Hoo Lee , Jung Dal Lee

Clin Mol Hepatol. 1997;3(4):316-328.

View: 2452 Download: 12

Serum Phospholipase A₂ Activities in Patients with Chronic Liver Disease

Jong Myung Lee , Young Oh Kweon , Nung Soo Kim

Clin Mol Hepatol. 1997;3(2):170-178. Published online January 1, 1970

View: 9261 Download: 12

Changes of Epidermal Growth Factor in Sera among the Patients with Chronic Hepatitis , Cirrhosis and Hepatocellular Carcinoma

Yong Hyeon Jo , Byeong Hoon Kim , Hong Ju Kim , Yeong Jung Cho , Je Lee , Jung Hae Choi , Seong Kyu Yang , Yong Koel Yoo , Kee Woon Kweon , Dong Hoo Lee

Clin Mol Hepatol. 1997;3(1):29-39.

View: 2541 Download: 14

Clinical Significance of Serum Concentration of Intercelluar Adhesion Molecule - 1 in Patients with Acute and Chronic Liver Disease

Sung Shick Lim , Seok Ho Dong , Hyo Jong kim , Byung Ho Kim , Rin Chang , Joung Il Lee

Clin Mol Hepatol. 1996;2(1):68-76. Published online January 1, 1970

View: 2450 Download: 17

A Study on the Efficacy and Safety of Dipheny - dimethyl - dicarboxylate in Patients with Chronic Liver disease

Hyoung Sik kim , Soo Taek Lee , Dae Gon kim , Deuk Soo Ahn

Clin Mol Hepatol. 1996;2(1):54-60.

View: 3753 Download: 101

Evaluation of Angiogenin Concentrations using ELISA in Sera from the Patients with Chronic Liver Diseases.

Kee Woon Kweon, Soong Hwan Lee, Seong Hee Lee, Hong Ju Kim, Chang Hwa Lee, Byoung Hun Kim, In Kyu Paik, Dong Il Park, Sung Soo Park, Dong Hoo Lee

Clin Mol Hepatol. 1996;2(1):29-36. Published online January 1, 2000

View: 58166 Download: 16

Clinical Significance of the Correlation of Serum ProcollagenⅠand Ⅲ Propeptide Concentrations in Chronic Liver Diseases

Dong Il Park , Soong Hwan Lee , In Kyu Paik , Yong Hyeon Cho , Yun hu Cho , Byoung Hun kim , Dong Hoo lee

Clin Mol Hepatol. 1996;2(1):13-20.

View: 2531 Download: 11

Correspondence

Reply to: “From invasive to intuitive: the emerging role of non-invasive models in hepatic decompensation”

Chuan Liu, Ling Yang, Hong You, Gao-Jun Teng, Xiaolong Qi

Received August 27, 2024 Accepted August 29, 2024

DOI: https://doi.org/10.3350/cmh.2024.0723 [Accepted]

View: 655 Download: 30

Editorial

Risk stratification for hepatocellular carcinoma in metabolic dysfunction-associated steatotic liver disease

Ho Soo Chun, Minjong Lee

Received February 2, 2025 Accepted February 7, 2025

DOI: https://doi.org/10.3350/cmh.2025.0116 [Accepted]

View: 257 Download: 14

1 |

Viewed By 7362	MAFLD: How is it different from NAFLD?
Viewed By 6913	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 5569	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 5338	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4765	Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease

Cited By 298	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 270	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 186	MAFLD: How is it different from NAFLD?
Cited By 93	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 92	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search